Anastasia A. Ignatova

Dr. Anastasia A. Ignatova


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2018 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
CAChristophe Alric
Christophe Alric
KHKatel Hervé-Aubert
Katel Hervé-Aubert
NANicolas Aubrey
Nicolas Aubrey
SMSouad Melouk
Souad Melouk
LLLaurie LAJOIE
Laurie LAJOIE
EAEmilie Allard-Vannier
Emilie Allard-Vannier
Recent advances in nanomedicine have shown the great interest of active targeting associated to nanoparticles. Single chain variable fragments (scFv) of disease-specific antibodies are very promising targeting entities because they are small, not immunogenic and able to bind their specific antigens. The present paper is devoted to biological properties in vitro and in vivo of fluorescent and pegylated iron oxide nanoparticles (SPIONs-Cy-PEG-scFv) functionalized with scFv targeting Human Epithelial growth Receptor 2 (HER2). Thanks to a site-selective scFv conjugation, the resultant nanoprobes demonstrated high affinity and specific binding to HER2 breast cancer cells. The cellular uptake of SPIONs-Cy-PEG-scFv was threefold higher than that for untargeted PEGylated iron oxide nanoparticles (SPIONs-Cy-PEG) and is correlated to the expression of HER2 on cells. In vivo, the decrease of MR signals in HER2+ xenograft tumor is about 30% at 24 h after the injection. These results all indicate that SPIONs-Cy-PEG-scFv are relevant tumor-targeting magnetic resonance imaging agents, suitable for diagnosis of HER2 overexpressing breast tumor.

13 December 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
Ekaterina FinkinaEkaterina Finkina
Ekaterina Finkina
Daria MelnikovaDaria Melnikova
Daria Melnikova
Ivan BogdanovIvan Bogdanov
Ivan Bogdanov
NMNataliya Matveevskaya
Nataliya Matveevskaya
AIAnastasia A. Ignatova
Anastasia A. Ignatova
TOTatiana V. Ovchinnikova
Tatiana V. Ovchinnikova
Previously, we isolated the lentil allergen Len c 3, belonging to the class of lipid transfer proteins, cross-reacting with the major peach allergen Pru p 3 and binding lipid ligands. In this work, the allergenic capacity of Len c 3 and effects of different lipid ligands on the protein stability and IgE-binding capacity were investigated. Impacts of pH and heat treating on ligand binding with Len c 3 were also studied. It was shown that the recombinant Len c 3 (rLen c 3) IgE-binding capacity is sensitive to heating and simulating of gastroduodenal digestion. While being heated or digested, the protein showed a considerably lower capacity to bind specific IgE in sera of allergic patients. The presence of lipid ligands increased the thermostability and resistance of rLen c 3 to digestion, but the level of these effects was dependent upon the ligand’s nature. The anionic lysolipid LPPG showed the most pronounced protective effect which correlated well with experimental data on ligand binding. Thus, the Len c 3 stability and allergenic capacity can be retained in the conditions of food heat cooking and gastroduodenal digestion due to the presence of certain lipid ligands.

19 February 2019 in Vox Sanguinis
Verified
Journal Article
Closed access
PDF file
PTPavel Trakhtman
Pavel Trakhtman
IKIrina Kumukova
Irina Kumukova
NSNikolay Starostin
Nikolay Starostin
DBDaria Borsakova
Daria Borsakova
DBDmitry Balashov
Dmitry Balashov
ARAlexander Rumiantcev
Alexander Rumiantcev

19 December 2019 in Platelets
Verified
Journal Article
Closed access
DPDmitrii Polokhov
Dmitrii Polokhov
NENikolay M. Ershov
Nikolay M. Ershov
AIAnastasia A. Ignatova
Anastasia A. Ignatova
EPEvgeniya A. Ponomarenko
Evgeniya A. Ponomarenko
MGMarina V. Gaskova
Marina V. Gaskova
MPMikhail A. Panteleev
Mikhail A. Panteleev
Childhood essential thrombocythemia (ET) is a rare chronic myeloproliferative disorder. The quality of life of ET patients may decrease as a result of ischemic and hemorrhagic complications of unclear origin. Our goal was to characterize the hemostatic system in children with ET. We genotyped and investigated blood samples from 20 children with ET in a prospective case series study using platelet aggregation, functional flow cytometry (FC) assay and standard clotting assays. Three children had a JAK2V617F mutation, 4 had mutations in CALR and 13 were triple-negative. Myelofibrosis in stage 1-2 was detected in 3 children. Three patients had bleeding episodes and seven had ischemic events. Aggregation in response to collagen, adenosine diphosphate, and ristomycin was decreased in all patients. In FC, significant changes in the whole patient group compared to the healthy children control group were decrease in the resting forward scatter and PAC1 binding (activated GPIIb/IIIa) level. For the activated platelets, dense granules release (by mepacrine), PAC1, and GPIIb/IIIa levels were significantly decreased. GPIb/V/IX, P-selectin, and phosphatidylserine levels manifested only moderate differences. Forward and side scatter changes in response to stimulation (representing shape change) and dense granules release were significantly lower in the 3 patients with bleeding than in the 17 patients without hemorrhage. Activated partial thromboplastin time was slightly prolonged, prothrombin index was slightly shortened and thrombin time was normal, while fibrinogen was mildly decreased in the ET patients. It could be concluded that the observed platelet function defects could be related to bleeding in ET, and be potentially used as a marker.

31 August 2022 in Membranes
Verified
Journal Article
Open access
PDF file
Ekaterina FinkinaEkaterina Finkina
Ekaterina Finkina
Ivan BogdanovIvan Bogdanov
Ivan Bogdanov
AIAnastasia A. Ignatova
Anastasia A. Ignatova
MKMarina D. Kanushkina
Marina D. Kanushkina
EEEkaterina A. Egorova
Ekaterina A. Egorova
TOTatiana V. Ovchinnikova
Tatiana V. Ovchinnikova
An increase in the frequency of mycoses and spreading of multidrug-resistant fungal pathogens necessitates the search for new antifungal agents. Earlier, we isolated the novel defensin from lentil Lensculinaris seeds, designated as Lc-def, which inhibited the growth of phytopathogenic fungi. Here, we studied an antifungal activity of Lc-def against human pathogenic Candida species, structural stability of the defensin, and its immunomodulatory effects that may help to prevent fungal infection. We showed that Lc-def caused 50% growth inhibition of clinical isolates of Candida albicans, C. krusei, and C. glabrata at concentrations of 25–50 μM, but was not toxic to different human cells. The lentil defensin was resistant to proteolysis by C. albicans and was not cleaved during simulated gastroduodenal digestion. By using the multiplex xMAP assay, we showed for the first time for plant defensins that Lc-def increased the production of such essential for immunity to candidiasis pro-inflammatory cytokines as IL-12 and IL-17 at the concentration of 2 μM. Thus, we hypothesized that the lentil Lc-def and plant defensins in general may be effective in suppressing of mucocutaneous candidiasis due to their antifungal activity, high structural stability, and ability to activate a protective immune response.

18 August 2019 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
AIAnastasia A. Ignatova
Anastasia A. Ignatova
IDIrina A. Demina
Irina A. Demina
VPVadim V. Ptushkin
Vadim V. Ptushkin
SKSvetlana G. Khaspekova
Svetlana G. Khaspekova
OSOlga N. Shustova
Olga N. Shustova
MPMikhail A. Panteleev
Mikhail A. Panteleev
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.